Open AccessTechnologically-Treated Polyclonal Affinity-Purified Antibodies to the Tumor Necrosis Factor-α, Brain Specific S-100 Protein and Histamine in Treatment of Functional Dyspepsia: Results of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Author(s) -
Yu. O. Shulpekova,
И. В. Маев,
В. Б. Гриневич,
И. Б. Хлынов,
Yu. G. Shvarts,
Ivashkin Vt
Publication year - 2022
Publication title -
rossijskij žurnal gastroènterologii, gepatologii, koloproktologii
Language(s) - English
Resource type - Journals
eISSN - 2658-6673
pISSN - 1382-4376
DOI - 10.22416/1382-4376-2022-32-3-40-51
Subject(s) - placebo , medicine , gastroenterology , randomized controlled trial , clinical trial , clinical endpoint , adverse effect , histamine , placebo controlled study , double blind , pathology , alternative medicine